Blockade of N-Methyl-D-Aspartate Receptor Prevents Hypoxic Neuronal Death and Cytokine Release

NeuroImmunoModulation

Volumn 4, Issue 4, 1997, Pages 195-199

  Di Loreto, Silvia ^a   Balestrino, Maurizio ^b   Pellegrini, Patrizia ^a   Bergliella, Anna Maria ^a   Del Beato, Tiziana ^a   Di Marco, Franca ^a   Adorno, Domenico ^a  

^a CNR   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

2 Amino 5 phosphonovaleric acid; Hypoxia; Interleukin 1; Ischemia; N Methyk D aspartate; Neuronal cultures; Neuronal death; Tumor necrosis factor

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; INTERLEUKIN 1BETA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL HYPOXIA; CYTOKINE RELEASE; EMBRYO; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 13144283695     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097338     Document Type: Article

References (29)

1. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system, I, Expression and recognition, Trends Ncurosci 1995:18:83-88.
2. Chung IY, Benveniste EN: TNFa production by astrocytes: Induction by lipopolysaccharidc, INFy and ILIß, J Immunol 1990; 144:2999-3007.
3. Brcdcr CD, Dinarello CA, Saper CB: Interleukin-1 immunoreactive innervation of the human hypothalamus, Science 1988:240:321-324.
4. Lieberman AP, Pitha PM, Shin HS, Shin ML: Production of TNFa and other cytokines by astrocytes stimulates with lipopolysaccharide or a ncurotrophic virus, Proc Natl Acad Sci USA 1989:86:6348-6352.
5. Pamet P, Amindari S, Wu C, Brunke-Rccse D, Goujon E, Wcyhenmeyer J, Dantzer R, Kelley K: Expression of type I and II intcrlcukin-1 receptors in mouse brain, Mol Brain Res 1994; 27:63-70.
6. Kinouchi K, Brone G, Pasternak G, Donner DB: Identification and characterization of receptors for TNFa in the brain, Biochcm Bio-phys ResCommun 1991;181:1532-1538.
7. Liu T, Clark RK, McDonnell PC, Youg PR, White RF, Barone FC, Fcucrdtcin GZ: Tumor necrosis factor-a expression in ischemic neurons, Stroke 1994:25:1481-1488.
8. Szafiarskii J, Burtruni D, Silverstein FS: Cerebral hypoxia-ischemia stimulates cy'tokinc gene expression in perinatal rats, Stroke 1995:26: 1093-1100.
9. Buttini M, Sauter A, Boddeke HWGM: Induction of interleukin-lß mRNA after focal cerebral ischacmia in the rat, Mol Brain Res 1994; 23:126-134.
10. Yabuuchi K, Minami M, Katsumata S, Yama-zaki A, Satoh M: An in situ hybridization study on intcrlcukin-1 ß mRNA induced by transient forebrain ischemia in the rat brain, Mol Brain Res 1994:26:135-142.
11. Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M: Convulsants induce intcrlcukin-1 ß messenger RNA in rat brain, Bio-chem Biophvs Res Commun 1990:171:832-837.
12. Giulian D, Woodward J, Young D, Krebs JF, Lachman LB: Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization, J Ncurosci 1989:8:2485-2490.
13. Saporito MS, Wilcox HM, Hartpcncc KC, Lewis ME, Vaught JL, Carswell S: Pharmacological induction of nen e growth factor mRNA in adult rat brain, Exp Neurol 1993;123:295-302.
14. Lindholm D, Heumann R, Meyer M, Thoenen H: lnterlcukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nen e, Nature 1987;330:658-659.
15. Cheng B, Christakos S, Mattson MP, Brown S: Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis, Neuron 1994:12:139-153.
16. Relton JK, Rothwell NJ: Interleukin-1 receptor antagonist inhibits neuronal damage induced by cerebral ischemia or NMDA-receptor activation in the rat, Brain Bull 1992;29:243-246.
17. Rothwell NJ, Relton JK: Involvement of interleukin-1 and lipocortin-l in ischaemic brain damage, Cerebrovasc Brain Metab Rev 1993:5: 178-198.
18. Di Loreto S, Balestrino M: Development of vulnerability to hypoxic damage in in vitro hippocampal neurons, Int J Dev Neurosci 1997: 15:225-230.
19. Rothman SJ: Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death, Neuroscience 1994:4:1884-1891.
20. Aitken PG, Balestrino M, Somjen GG: NMDA antagonists: Lack of protective effect against hypoxic damage in CA I region of hippocampal slices, Ncurosci Lett 1988:89:187-192.
21. Aitken PG, Balestrino M, Somjen GG: NMDA antagonists: Lack of protective effects against hypoxic damage in Cal region of hippocampal slices, Neurosci Lett 1988:89/2:187-192.
22. Teli G, Mancuso G, Tomasello F: Cytokine apparence and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection, Infect Immun 1993:61:227-235.
23. Shohami E, Gallily R, Mehoulam R, Bass R, Benhur T: Cytokine production in the brain following closed head injury-dexanabinol (HU 211) is a novel TNF-alpha inhibitor and effective ncuroprotectant, J Ncuroimmunol 1997;72:169-177.
24. Piani D, Spranger M, Frei K, Schelfer A, Fontana A: Macrophage-induccd cytotoxicity of N-methyl-D-aspartatc receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines, EurJ Immunol 1992:22:2429-2436.
25. Strijbos PJLM, Rothwcll NJ: Interleukin-1 attenuates excitatory amino acid induced neural degeneration in vitro: Involvement of nerve growth factor, J Ncurosci 1995; 15:3468-3474.
26. Aloisi F, Borsellino G, Care A, Tasta U, Gallo P, Russo G, Peschle C, Levi G: Cytokine regulation of astrocyte function: In-vitro studies using cells from the human brain, Int J Dev Neurosci 1995:13:265-274.
27. Pellegrini P, Berghella AM, Di Loreto S, Del Beato T, Di Marco F, Adorno D, Casciani CU: Cytokine contribution to the repair processes and homeostasis recovery following anoxic insult: A possible IFN-y-regulating role in IL-Iß ncurotoxic action in physiological or damaged CNS, Neuroimmunomodulation 1996:3:213-218.
28. Hernandez-Carceres J, Maclas-Gonzalcs R, Brozck G, Bures J: Systemic ketamine blocks cortical spreading depression but does not delay the onset of terminal anoxic depression, Brain Res 1987:437:360-364.
29. Marranes R, De Prins E, Willems R, Wauguier A: NMDA antagonists inhibit cortical spreading depression, but accelerate the onset of neuronal depolarization induced by asphyxia: in Somjen G (ed): Mechanisms of Cerebral Hypoxia and Stroke, New York, Plenum Publishing, 1988.